TrialFrontiers in aging2026

Nicotinamide riboside and pterostilbene reduces frequency and severity of undesirable symptoms of the menopause transition: an open-label, pilot clinical trial.

Holly E Holmes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.